3-氨基异烟酸甲酯 | 64188-97-2

• 物质功能分类: 医药中间体 - 杂环化合物 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 中文名称: 3-氨基异烟酸甲酯
• 中文别名: 3-氨基吡啶-4-甲酰胺；3-氨基异烟酰胺
• 英文名称: 3-aminoisonicotinamide
• 英文别名: 3-aminopyridine-4-carboxamide
• CAS: 64188-97-2
• 化学式: C₆H₇N₃O
• mdl: MFCD08235178
• 分子量: 137.141
• InChiKey: MRZUGOPPUMNHGA-UHFFFAOYSA-N

物化性质

• 熔点：
  84-86°
• 沸点：
  369.2±22.0 °C(Predicted)
• 密度：
  1.323±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  82
• 氢给体数：
  2
• 氢受体数：
  3

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P280,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H332,H335
• 储存条件：
  储存条件：2-8°C，避光，惰性气体环境。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Amino-4-pyridinecarboxamide
Synonyms: 3-Aminoisonicotinamide

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Amino-4-pyridinecarboxamide
CAS number: 64188-97-2

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H7N3O
Molecular weight: 137.1

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-氨基异烟酸甲酯 在 4-二甲氨基吡啶 、 2,4,6-三异丙基苯磺酰氯 、 potassium 2-methylbutan-2-olate 、 三乙胺 作用下， 以 四氢呋喃 、 N,N-二甲基乙酰胺 、 甲苯 为溶剂， 反应 1.0h， 生成 (R)-3-[2-(2-chloropyridin-4-yl)pyrido[3,4-d]pyrimidin-4-ylamino]pyrrolidine-1-carboxylic acid tert-butyl ester
  参考文献：
  名称：

  [EN] AZAQUINAZOLINE INHIBITORS OF ATYPICAL PROTEIN KINASE C
  [FR] INHIBITEURS DE TYPE AZAQUINAZOLINE DE PROTÉINE KINASE C ATYPIQUE

  摘要：

  公开号：

  WO2014052699A9
• 作为产物：
  描述：

  异烟酸 在 氯化铵 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以47%的产率得到3-氨基异烟酸甲酯
  参考文献：
  名称：

  通过铁催化的NH和CH键之间的交叉脱氢偶联（CDC）合成2-芳基喹唑啉酮。

  摘要：

  在这里，我们描述了通过甲基芳烃和邻氨基苯甲酰胺之间的交叉脱氢偶联直接合成喹唑啉酮。苄sp。的C-H官能化3碳被二-实现吨丁基过氧化物在空气下，和随后的胺化需氧氧化过程完成环过程。铁催化了整个反应过程，在反应条件下可耐受各种官能团，提供了31种使用甲基芳烃衍生物的2-芳基喹唑啉酮实例，收率为57–95％。合成潜力已通过含芳基杂环的额外合成得到证明。

  DOI：

  10.1039/d0ob00866d

文献信息

• Method of treating a patient having precancerous lesions with phenyl
  申请人：Cell Pathways, Inc.

  公开号：US06060477A1

  公开（公告）日：2000-05-09

  Derivatives of Phenyl Cycloamino Pyrimidinone are useful for the treatment of patients having precancerous lesions. These compounds are also useful to inhibit growth of neoplastic cells.

  苯基环氨基嘧啶酮的衍生物对于治疗患有癌前病变的患者是有用的。这些化合物还可用于抑制肿瘤细胞的生长。
• Chemical compounds
  申请人：Smith Kline & French Laboratories, Ltd.

  公开号：US05047404A1

  公开（公告）日：1991-09-10

  This invention relates to fused pyrimidine derivatives which have bronchodilator and anti-allergic activities. A compound of the invention is 2-(2-propoxyphenyl)pyrido[2,3-d]pyrimid-4(3H)-one.

  这项发明涉及具有支气管扩张剂和抗过敏活性的融合嘧啶衍生物。该发明的化合物是2-(2-丙氧基苯基)吡啶并[2,3-d]嘧啶-4(3H)-酮。
• One-Step Synthesis of 2-Chloropyrimidin-4-ol Derivatives: An Unusual Reactivity of Thiophosgene
  作者：Michael Callingham、Francesca Blum、Grégoire Pavé

  DOI：10.1021/acs.orglett.5b02375

  日期：2015.10.2

  A novel, high-yielding, one-step synthesis of 2-chloroquinazolin-4-ols and analogous bicycles from 2-aminoamides using thiophosgene is described. The scope of the reaction includes aminothioamides, amino acids, and fused heterocycle derivatives, furnishing quinazolines, oxazinones, and substituted fused pyrimidine bicycles, respectively. On the basis of observed results with substituted analogues,

  描述了一种使用硫光气从2-氨基酰胺合成2-氯喹唑啉-4-醇和类似自行车的新型，高产一步法。反应范围包括氨基硫代酰胺，氨基酸和稠合的杂环衍生物，分别提供喹唑啉，恶嗪酮和取代的稠合嘧啶自行车。根据用取代的类似物观察到的结果，认为这种转变的机理是通过异硫氰酸酯中间体发生的，然后是硫光气在硫醇中间体上的意外的化学选择性反应。
• Substrate Profiling of the Cobalt Nitrile Hydratase from Rhodococcus rhodochrous ATCC BAA 870
  作者：Adelaide R. Mashweu、Varsha P. Chhiba-Govindjee、Moira L. Bode、Dean Brady

  DOI：10.3390/molecules25010238

  日期：——

  cross-coupling reactions and imidazo[1,2-a]pyridines prepared by the Groebke–Blackburn–Bienaymé multicomponent reaction. The enzyme active site was moderately accommodating, accepting almost all of the small aromatic nitriles, the diarylpyridines and most of the bi-aryl compounds and Morita–Baylis–Hillman products but not the Groebke–Blackburn–Bienaymé products. Nitrile conversion was influenced by steric

  对来自玫瑰色红球菌 ATCC BAA 870 的钴腈水合酶的芳香底物特征进行了评估，并针对多种含腈化合物 (>60)。为了确定这种酶的底物限度，评估了大小从小 (90 Da) 到大 (325 Da) 的化合物。较大的化合物包括通过 Suzuki 偶联反应制备的具有双芳基轴的化合物、Morita-Baylis-Hillman 加合物、通过 Buchwald-Hartwig 交叉偶联反应制备的杂原子连接的二芳基吡啶和通过制备的咪唑并 [1,2-a] 吡啶Groebke-Blackburn-Bienaymé 多组分反应。酶活性位点适中，接受几乎所有的小芳香腈，二芳基吡啶和大多数双芳基化合物和 Morita-Baylis-Hillman 产品，但不是 Groebke-Blackburn-Bienaymé 产品。腈的转化率受氰基周围的空间位阻、芳环上给电子基团（例如甲氧基）的存在以及化合物的整体大小的影响。
• [EN] SUBSTITUTED QUINOXALINE DERIVATIVES<br/>[FR] DÉRIVÉS DE QUINOXALINE SUBSTITUÉS
  申请人：SELVITA S A

  公开号：WO2016180537A1

  公开（公告）日：2016-11-17

  The present invention relates to substituted quinoxaline derivatives. These compounds are useful for the prevention and/or treatment of several medical conditions including hyperproliferative disorders and diseases.

  这项发明涉及取代喹喔啉衍生物。这些化合物对预防和/或治疗包括过度增殖性疾病在内的多种医疗状况具有用处。